The phrase "sequential reduction" is grammatically correct and can be used in written English.
It refers to the process of reducing something in a sequential or gradual manner. It is commonly used in technical or scientific writing to describe step-by-step reductions or simplifications. Example: The researchers utilized a sequential reduction approach to simplify the complex mathematical model, allowing for a more efficient analysis of the data.
The model reproduced the sequential reduction reaction.
A magnetically separable core-shell-like catalyst Ni-Pd/CB is designed and synthesized via a facile sequential reduction strategy.
Ni2P is formed by sequential reduction and phosphidation reactions and therefore its preparation demands careful adjustment of the synthesis conditions.
The structures are presented alongside activity data that depict the sequential reduction of GGPP to H6GGPP via the intermediates H2GGPP and H4GGPP.
A borohydride reduction technique was used for the preparation of the monometallic NPs, while a sequential reduction strategy was seen to generate the putative core shell varieties.
A solution-based chemical approach has been used to prepare silver nanoparticle graphene (Ag G) hybrids through sequential reduction of graphene oxidation and silver ions.
Eleven patients demonstrated sequential reductions in Ki-67 LI throughout the two study periods, and four patients showed sequential increases during therapy.
In the 11 patients who showed sequential reductions in Ki-67 throughout the study period, nine (82%) achieved a clinical response (p = 0.019).
Indeed, use of increasingly prolonged cut-offs of ≥12, ≥18 and ≥24 weeks was associated with sequential reductions in the numbers of patients that would require tracing.
Rather, there is growing evidence for increased aggressiveness and adaptation by pathogen isolates to partially resistant host lines and thus sequential reductions in the disease control benefit gained from such resistance.
In addition, the treatment with antidiabetic agents, including glucagon-like peptide-1 (GLP-1) receptor agonists, exendin-4, and liraglutide, which are approved for the treatment of T2DM, has been shown to facilitate insulin signaling and sequential reductions in the endogenous levels of A β in the brain and prevent hippocampal neuronal death [ 80].
